Jens M Kelm

发表

Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods.

Chihae Yang, Brett A Lidbury, Marcel Leist, 2012, ALTEX.

Translational in vitro research: integrating 3D drug discovery and development processes into the drug development pipeline.

Marc Ferrer, Jens M Kelm, Madhu Lal-Nag, 2019, Drug discovery today.

96-Well Format-Based Microfluidic Platform for Parallel Interconnection of Multiple Multicellular Spheroids

Andreas Hierlemann, Olivier Frey, Jin-Young Kim, 2015, Journal of laboratory automation.

Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types.

Martin Fussenegger, Jens M Kelm, Nicholas E. Timmins, 2003, Biotechnology and bioengineering.

Microscale tissue engineering using gravity-enforced cell assembly.

Martin Fussenegger, Jens M Kelm, M. Fussenegger, 2004, Trends in biotechnology.

Development and Characterization of a Scaffold-Free 3 D Spheroid Model of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes

Wolfgang Moritz, Irina Agarkova, Jens M Kelm, 2015 .

Scaffold-free cell delivery for use in regenerative medicine.

Martin Fussenegger, Jens M Kelm, M. Fussenegger, 2010, Advanced drug delivery reviews.

Hepatic toxicology following single and multiple exposure of engineered nanomaterials utilising a novel primary human 3D liver microtissue model

Steffen Loft, Peter Møller, Vicki Stone, 2014, Particle and Fibre Toxicology.

An in vitro osteosarcoma 3D microtissue model for drug development.

Ursula Graf-Hausner, Markus Rimann, Jens M Kelm, 2014, Journal of biotechnology.

Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues.

Wolfgang Moritz, Jan Lichtenberg, Jens M Kelm, 2011, Biotechnology journal.